Tomás Vega

24.1k total citations
31 papers, 1.0k citations indexed

About

Tomás Vega is a scholar working on Epidemiology, Physiology and Modeling and Simulation. According to data from OpenAlex, Tomás Vega has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 6 papers in Physiology and 5 papers in Modeling and Simulation. Recurrent topics in Tomás Vega's work include Influenza Virus Research Studies (13 papers), Respiratory viral infections research (10 papers) and COVID-19 epidemiological studies (5 papers). Tomás Vega is often cited by papers focused on Influenza Virus Research Studies (13 papers), Respiratory viral infections research (10 papers) and COVID-19 epidemiological studies (5 papers). Tomás Vega collaborates with scholars based in Spain, Netherlands and Sweden. Tomás Vega's co-authors include José Eugenio Lozano Alonso, Luis H. Martín Arias, Ana Alvarez-Requejo, Alfonso Carvajal, Bernard Bégaud, Yola Moride, René Snacken, Raúl Ortíz de Lejarazu, T J Meerhoff and Joshua A. Mott and has published in prestigious journals such as Blood, Vaccine and Industrial Marketing Management.

In The Last Decade

Tomás Vega

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomás Vega Spain 17 491 191 144 139 120 31 1.0k
Dolores Montero Spain 16 333 0.7× 5 0.0× 47 0.3× 69 0.5× 48 0.4× 35 1.3k
Angel Wong United Kingdom 18 143 0.3× 26 0.1× 8 0.1× 46 0.3× 30 0.3× 48 1.2k
Dharamveer Yadav India 16 116 0.2× 26 0.1× 19 0.1× 8 0.1× 52 0.4× 51 856
Maurizio Sessa Denmark 21 97 0.2× 4 0.0× 27 0.2× 240 1.7× 61 0.5× 96 1.3k
Aurore Palmaro France 17 158 0.3× 3 0.0× 77 0.5× 113 0.8× 79 0.7× 42 1.2k
Jane Masoli United Kingdom 16 124 0.3× 25 0.1× 31 0.2× 5 0.0× 25 0.2× 37 1.2k
María Antonietta Barbieri Italy 18 95 0.2× 7 0.0× 16 0.1× 77 0.6× 18 0.1× 66 802
Narjes Saheb Sharif‐Askari United Arab Emirates 17 115 0.2× 14 0.1× 6 0.0× 21 0.2× 58 0.5× 81 1.1k
Fatemeh Saheb Sharif‐Askari United Arab Emirates 17 102 0.2× 14 0.1× 5 0.0× 21 0.2× 50 0.4× 71 1.1k
Stefania Spila Alegiani Italy 17 240 0.5× 15 0.1× 10 0.1× 5 0.0× 26 0.2× 58 969

Countries citing papers authored by Tomás Vega

Since Specialization
Citations

This map shows the geographic impact of Tomás Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomás Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomás Vega more than expected).

Fields of papers citing papers by Tomás Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomás Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomás Vega. The network helps show where Tomás Vega may publish in the future.

Co-authorship network of co-authors of Tomás Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Tomás Vega. A scholar is included among the top collaborators of Tomás Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomás Vega. Tomás Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vega, Tomás, Erik A. Jensen, Catherine M. Avitabile, et al.. (2025). Pulmonary vasodilator use in very preterm infants in United States children’s hospitals. Journal of Perinatology. 45(10). 1382–1388. 1 indexed citations
2.
Coronado‐Zamora, Marta, Katrin Beyer, Tomás Vega, et al.. (2023). Complete mitochondrial DNA profile in stroke: A geographical matched case-control study in Spanish population. Mitochondrion. 73. 51–61. 1 indexed citations
3.
Vega, Tomás, et al.. (2022). Genetic, environmental and life-style factors associated with longevity. Protocol and response of the LONGECYL Study. Gaceta Sanitaria. 36(3). 260–264. 1 indexed citations
4.
López‐Ortiz, Susana, Pedro L. Valenzuela, Javier S. Morales, et al.. (2021). Exercise interventions in Alzheimer’s disease: A systematic review and meta-analysis of randomized controlled trials. Ageing Research Reviews. 72. 101479–101479. 83 indexed citations
5.
Vega, Tomás, et al.. (2019). Evaluating tools to define influenza baseline and threshold values using surveillance data, Egypt, season 2016/17. Journal of Infection and Public Health. 13(3). 430–437. 12 indexed citations
6.
Grgurević, Anita, Goran Trajković, Boban Mugoša, et al.. (2019). Influenza surveillance: determining the epidemic threshold for influenza by using the Moving Epidemic Method (MEM), Montenegro, 2010/11 to 2017/18 influenza seasons. Eurosurveillance. 24(12). 18 indexed citations
7.
8.
Rojas‐Fernández, Alejandro, Tomás Vega, Pablo Achurra, et al.. (2017). Diarrea poscolecistectomía: ¿un problema frecuente?. Revista Chilena de Cirugía. 69(5). 376–381. 2 indexed citations
9.
Gherasim, Alin, Francisco Pozo, Salvador de Mateo, et al.. (2016). Waning protection of influenza vaccine against mild laboratory confirmed influenza A(H3N2) and B in Spain, season 2014–15. Vaccine. 34(20). 2371–2377. 21 indexed citations
10.
Bangert, Mathieu, Horacio Gil, Jesús Oliva, et al.. (2016). Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM). Epidemiology and Infection. 145(4). 715–722. 9 indexed citations
11.
12.
Fernández‐Bergés, Daniel, Luciano Consuegra‐Sánchez, Judith Peñafiel, et al.. (2014). Metabolic and Inflammatory Profiles of Biomarkers in Obesity, Metabolic Syndrome, and Diabetes in a Mediterranean Population. DARIOS Inflammatory Study. Revista Española de Cardiología (English Edition). 67(8). 624–631. 18 indexed citations
13.
Jiménez‐Jorge, Silvia, Salvador de Mateo, Concepción Delgado‐Sanz, et al.. (2013). Effectiveness of influenza vaccine against laboratory-confirmed influenza, in the late 2011–2012 season in Spain, among population targeted for vaccination. BMC Infectious Diseases. 13(1). 441–441. 37 indexed citations
14.
Hauswirth, Alexander W., Júlia Almeida, Wendy G. Nieto, et al.. (2012). Monoclonal B‐cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B‐cell subsets. American Journal of Hematology. 87(7). 721–724. 12 indexed citations
15.
Vega, Tomás, José Eugenio Lozano Alonso, T J Meerhoff, et al.. (2012). Influenza surveillance in Europe: establishing epidemic thresholds by the Moving Epidemic Method. Influenza and Other Respiratory Viruses. 7(4). 546–558. 136 indexed citations
16.
Vega, Tomás, et al.. (2011). Atención sanitaria paliativa y de soporte de los equipos de atención primaria en el domicilio. Gaceta Sanitaria. 25(3). 205–210. 23 indexed citations
17.
Vega, Tomás, et al.. (2008). Stroke in Spain: Epidemiologic Incidence and Patterns; A Health Sentinel Network Study. Journal of Stroke and Cerebrovascular Diseases. 18(1). 11–16. 49 indexed citations
18.
Paget, W J, et al.. (2003). Heterogeneous case definitions used for the surveillance of influenza in Europe. European Journal of Epidemiology. 18(8). 751–754. 55 indexed citations
19.
Alvarez-Requejo, Ana, Alfonso Carvajal, Bernard Bégaud, et al.. (1998). Under-reporting of adverse drug reactions. European Journal of Clinical Pharmacology. 54(6). 483–488. 195 indexed citations
20.
Vega, Tomás, et al.. (1991). Why U.S. firms don't buy from Latin American companies. Industrial Marketing Management. 20(3). 207–213. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dolores Montero Breakdown of academic impact, for papers by Angel Wong Breakdown of academic impact, for papers by Dharamveer Yadav Breakdown of academic impact, for papers by Maurizio Sessa Breakdown of academic impact, for papers by Aurore Palmaro Breakdown of academic impact, for papers by Jane Masoli Breakdown of academic impact, for papers by María Antonietta Barbieri Breakdown of academic impact, for papers by Narjes Saheb Sharif‐Askari Breakdown of academic impact, for papers by Fatemeh Saheb Sharif‐Askari Breakdown of academic impact, for papers by Stefania Spila Alegiani
Rankless by CCL
2026